Table of Contents
Women across the country are coming forward after experiencing serious complications following breast surgeries involving GalaFLEX and Phasix surgical mesh products. These meshes, sometimes marketed as part of an “internal bra” procedure, have been used in breast reconstruction, augmentation, and reduction surgeries despite concerns that they were not approved by the FDA specifically for breast procedures.
Lawsuits are currently being investigated against the manufacturers of GalaFLEX and Phasix mesh for allegedly failing to properly warn patients and medical providers about the potential risks associated with these products.
What Is GalaFLEX & Phasix Mesh?
GalaFLEX and Phasix are surgical mesh products designed to provide soft tissue support. In breast procedures, surgeons may use the mesh to reinforce breast implants or tissue, often referring to the technique as an “internal bra.” However, many patients later experienced complications that required additional medical treatment or revision surgeries.
Reported Complications
Women who received GalaFLEX or Phasix mesh during breast surgery have reported serious complications, including:
- Nerve damage
- Infection or abscess occurring 60 or more days after implantation
- Seroma
- Capsular contracture
- Mesh migration or displacement
- Explant or revision surgery
- Reconstructive failure
- Implant rupture
- Skin necrosis
These complications may lead to significant pain, emotional distress, disfigurement, and costly medical care.
Who May Qualify for a Lawsuit?
You may qualify to pursue a GalaFLEX or Phasix breast mesh lawsuit if all of the following apply:
- You are female
- You underwent breast reconstruction, augmentation, or reduction surgery between 2015 and the present
- GalaFLEX or Phasix mesh was implanted during the procedure
- You later experienced one or more qualifying complications after implantation
Contact Our Firm
If you or a loved one experienced complications after a breast surgery involving GalaFLEX or Phasix mesh, you may have legal options.
Written By Donald Marcari
Don is the Senior Managing Partner at Marcari, Russotto, Spencer & Balaban. He gained national attention when his exploits as a defense attorney with the U.S. Navy JAG Corps became the basis for “A Few Good Men.”
